Public COA audit
NAD+ · NAD+ 1000mg
Audited July 28, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 88
- Confidence
- 85%
- Panels
- 4/7
- Purity (printed)
- 99.24%
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- NAD1000-062026-2
- Identity method
- LC-MS
- Sample date
- 2026-06-24
- Issue date
- 2026-06-26
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
4 of 7 present · 4 passed · 0 failed · 0 reported · 3 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Tested · passed · core
Compound identity confirmed (e.g. HPLC, mass spec).
NAD+ Confirmed
Purity
Tested · passed · core
Reported purity percentage for the analyte.
99.24%
Heavy metals
Not on this COA
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Microbial
Tested · passed
Bioburden / microbial limits testing.
No Detectable Microbial DNA
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
Pass (≤0.05 EU/mL)
Sterility
Not on this COA
Sterility testing where applicable.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
Residual solvent / water
Not on this COA
Residual solvents or water content limits.
No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing
Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
High purity confirmed
HPLC-UV purity of 99.24% is within normal range for research-grade NAD+. Two vials tested with consistent results (99.23% and 99.24%).
Identity confirmed by LC-MS
Mass spectrometry confirmation provided with chromatogram showing clean NAD+ peak. Mass spectrum included showing expected fragmentation pattern.
Comprehensive safety testing
Endotoxin testing (USP <85> compliant) and microbial analysis (PCR-based) both passed. Duplicate endotoxin replicates performed.
Batch information complete
Lot number NAD1000-062026-2 clearly stated. Net content measured for both vials (98.40 mg and 105.35 mg, average 101.88 mg).
Dates appropriate
Received 2026-06-24, reported 2026-06-26. Two-day turnaround is reasonable for this testing scope.
Lab verification limited
Freedom Diagnostics Testing website and contact provided, but no accreditation logos (ISO 17025, GMP, etc.) visible on COA. Search code provided for verification (Whol2606240018).
Missing panels
Heavy metals, sterility, and residual solvent/water content testing not performed. This is common for basic research-grade testing but limits comprehensive quality assessment.
Professional presentation
Well-formatted COA with clear sections, appropriate disclaimers for research use only, signature present, chromatogram and mass spectrum included.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.